The present invention relates to novel, non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
本发明涉及一种新型的非次生类
固醇苯基
呋喃化合物,具有
维生素D受体(VDR)调节活性,其低于1α,25-二羟基
维生素D3的高
钙血症作用。这些化合物可用于治疗骨病和牛皮癣。